Cargando…
A systematic review and integrated analysis of biologics that target Type 2 inflammation to treat COPD with increased peripheral blood eosinophils
BACKGROUND AND AIMS: Biologics that target Type 2 inflammation are effective in reducing exacerbations of severe asthma. We conducted a systematic review and integrated analysis of the efficacy and safety of these biologics in chronic obstructive pulmonary disease (COPD) patients with increased peri...
Autores principales: | Ohnishi, Hiroshi, Eitoku, Masamitsu, Yokoyama, Akihito |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218150/ https://www.ncbi.nlm.nih.gov/pubmed/35756113 http://dx.doi.org/10.1016/j.heliyon.2022.e09736 |
Ejemplares similares
-
Clinical utility of fractional exhaled nitric oxide and blood eosinophils counts in the diagnosis of asthma–COPD overlap
por: Takayama, Yusuke, et al.
Publicado: (2018) -
Peripheral Blood Eosinophils and Nine Years Mortality in COPD Patients
por: Prudente, Robson, et al.
Publicado: (2021) -
Eosinophilic airway inflammation in COPD
por: Saha, Shironjit, et al.
Publicado: (2006) -
Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD
por: Negewo, Netsanet A, et al.
Publicado: (2016) -
Blood Eosinophils and Pulmonary Rehabilitation in COPD
por: Aljazeeri, Jafar, et al.
Publicado: (2021)